Blog Post: Day 4 of $QQQ short term up-trend; $PANW has cup and handle and GLB to ATH, to report earnings on 11/20 | Wishing Wealth Blog Skip to content Screenshot Related Categories All Posts Source link
The incoming Trump administration is proposing tariffs on imports, especially against China. Many are divided over this.. I’ll show why tariffs could usher a new dawn in global trade. You’ve seen how markets responded positively since President Trump’s confirmed victory in the US election. Global stocks and cryptos staged a solid rally. Meanwhile gold and…
‘“I will not rest until we have delivered the strong, safe and prosperous America that our children deserve and that you deserve,” said Donald Trump in his victory speech. “This will truly be the golden age of America. That’s what we have to have. This is a magnificent victory for the American people that will…
STOCK (FUTURE / CASH / OPTION ) NIFTY (FUTURE / OPTION) BANK NIFTY (FUTURE / OPTION) FUTURE STOCK TIPS: IPCALAB (NOV. FUT.) BUY ABOVE 1530 TGT 1550/1570/1590 S/L 1527 AND SELL BELOW 1527 TGT 1520/1510/1500 S/L 1530 UPL (NOV. FUT.) BUY ABOVE 518 TGT…
share this article! [#item_full_content] Read More share this article! Source link
Tuesday: • At 6:00 AM ET, NFIB Small Business Optimism Index for October. • At 2:00 PM, Senior Loan Officer Opinion Survey on Bank Lending Practices (SLOOS) for October. Source link
Source link
Some stuff I am reading today morning: Monthly SIP value hits 25,000 Cr ( FE ) INR may depreciate by 10% in Trump 2.0 ( DH ) SEBI broadens UPSI definition ( Fortune ) Ramco : A concrete case of conflict ( Money Life ) Startup : SpotDraft ( Forbes ) Interview with Jim Bianco…
DALLAS (AP) — Southwest Airlines is offering buyouts and extended leaves of absence to airport workers to avoid what it calls “overstaffing in certain locations,” which it blames on a shortage of new planes from Boeing. The move on Monday comes as a hedge fund presses Southwest to increase profits and boost the stock price,…
(Reuters) -Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring program. “We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core consumer…